首页> 美国卫生研究院文献>Acute Medicine Surgery >Use and effectiveness of a two‐level initiation strategy for fixed‐dose prothrombin complex concentrate according to the initial international normalized ratio in an emergency department in Japan
【2h】

Use and effectiveness of a two‐level initiation strategy for fixed‐dose prothrombin complex concentrate according to the initial international normalized ratio in an emergency department in Japan

机译:根据日本急诊部门的初始国际标准化比例对固定剂量凝血酶组合物复合物的两级起始策略的使用和有效性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Prothrombin complex concentrate (PCC) was recently approved for patients on warfarin therapy with international normalized ratios (INRs) exceeding 2 in Japan. However, rapid normalization of INR is necessary even in patients who do not meet the aforementioned criteria. We previously found that a fixed PCC dose of 500 IU is insufficient in some patients with INR elevation but is effective in patients with INR less than 2.5. On the basis of the results, we revised the protocol to administer a PCC dose of 500 IU to patients with INR less than 2.5 or 1,000 IU to patients with higher INRs. This study aimed to validate this revised protocol at an emergency department (ED) in Japan.
机译:最近批准凝血酶原浓缩物(PCC),以促进日本的国际规范化比率(INRS)批准华林治疗患者。然而,即使在不符合上述标准的患者中,也是必要的inr的快速标准化。我们以前发现固定的PCC剂量为500 IU的某些患者在INR升级患者中不足,但患者有效的INR小于2.5。在结果的基础上,我们修订了向患有较高INR的患者施用500 IU的PCC剂量为500 IU的PCC剂量。本研究旨在在日本的急诊部(ED)验证此修订议定书。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号